This page was printed from the Northern & Eastern Devon Formulary and Referral site at
Please ensure you are using the current version of this document
This is a summary of the NEW Devon CCG commissioning policy for focal hyperhidrosis.
Treatments for focal hyperhidrosis are commissioned in the following circumstances:
Topical aluminium Chloride preparations may be prescribed for patients with a hyperhidrosis disease severity score of 2 or greater (sweating is tolerable but sometimes interferes with daily activities).
In patients with a Hyperhidrosis Disease Severity Scale score of 3 or more (sweating which is barely tolerable and frequently interferes with daily activities) which has failed to respond to treatment for at least one month with topical aluminium, the following specialist services are commissioned through direct referral to the department of dermatology:
Botulinum toxin is commissioned for use in patients with palmoplantar hyperhidrosis who have not achieved a 50% reduction in sweat production with the above treatments. Botulinum toxin for use in patients with axillary hyperhidrosis in whom the above treatments have proven unsuccessful and who have a resting sweat production per axilla of greater than 50mg in 5 minutes.
Surgical treatment with endoscopic thoracic sympathectomy for severe resistant axillary or palmar hyperhidrosis may be offered with explanation of the risk, benefits and side effects of the procedure.
Where the circumstances of treatment for an individual patient do not meet the criteria described above exceptional funding can be sought. Individual cases will be reviewed by the appropriate panel of the CCG upon receipt of a completed application from the patient's GP, consultant or clinician. Applications cannot be considered from patients personally.
Applications for consideration for funding approval should be sent to:
Alternatively, please send to: The Panel administrator at Bridge House, Collett Way, Newton Abbot, TQ12 4PH
Publication date: May 2013